[Properties] White or almost white crystaler; almost odorless. [Indications] Used for â primary and secondary hyperuricemia, especially hyperuricemia caused by excessive uric acid production; â¡ patients with recurrent or chronic gout; ⢠to; ⣠uric acid kidney stones And (or) uric acid neopathy; ⤠Hyperuricemia with renal insufficiency. [Contraindications] People who are allergic to this product, severe liver and kidney dysfunction, and obvious hypocytosis are contraindicated. ãValidity Periodã24 months. [Packing] Aluminum-plastic composite film bag. [Storage] shading, sealed and stored. [Product introduction] This product is a drug that inhibits the synthesis of uric acid. Allopurinol and its metabolite oxypurinol can inhibit xanthine oxidase and prevent hypoxanthine and xanthine from being metabolized into uric acid, thereby reducing the production of uric acid. Reduce the uric acid content in blood and urine to below the solubility level, prevent uric acid from forming crystals and depositing in joints and other tissues, and also help the uric acid crystals in the tissues of gout patients to re-dissolve. Allopurinol also inhibits the synthesis of new purines in the body by acting on hypoxanthine-guanine snuclease.